Opportunity Information: Apply for RFA CA 19 032

This National Institutes of Health funding opportunity (RFA-CA-19-032) supports R01 grant applications focused on cancers that occur in people living with HIV or with a diagnosis of AIDS. The central aim is to improve understanding of cancer risk, how these malignancies develop and progress, how they can be diagnosed more effectively, and how they can be treated in the context of underlying HIV infection. A key feature of the announcement is that it is structured around a small, targeted set of research challenges called "Provocative Questions" (PQs). These PQs are intentionally framed to push investigators toward understudied problems and apparent paradoxes in HIV-associated cancer research, rather than to cover the entire landscape of National Cancer Institute priorities in this area.

Applications must be tightly aligned to the PQ format: each proposed project has to choose one and only one of the six designated Provocative Questions and build the research plan around that specific question. In other words, the proposal is not meant to be a broad program covering multiple unrelated aims; it should be a coherent, hypothesis-driven (or otherwise rigorously justified) project that directly addresses the selected PQ. The FOA also encourages cross-cutting, transdisciplinary approaches when they strengthen the science behind the chosen PQ, meaning applicants can combine methods and perspectives from multiple fields (for example, oncology, virology, immunology, epidemiology, genomics, implementation science, behavioral science, pathology, bioinformatics, or health services research) as long as the work remains clearly focused on the single PQ target.

The grant mechanism is an NIH R01, with clinical trials listed as optional, which means applicants may propose either non-clinical-trial research or a study that includes a clinical trial component if it is appropriate to answering the selected question and meets NIH requirements. The activity category is health and education, and the program is associated with CFDA numbers 93.393 and 93.395. While the announcement text emphasizes scientific priorities and project structure, it does not provide an award ceiling or an expected number of awards in the provided source data.

Eligibility is broad and includes many types of U.S.-based organizations as well as certain non-U.S. entities. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (when not an institution of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based and community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and foreign (non-U.S.) organizations.

From a timing standpoint, the opportunity was created on January 24, 2019, and the original closing date shown in the source data is August 3, 2020. Overall, the FOA is best understood as a targeted research push: it is not asking for any HIV-and-cancer project in general, but for carefully designed R01 studies that squarely tackle one of six specific, high-impact questions that NCI viewed as important yet insufficiently addressed in the existing HIV-associated cancer research portfolio.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393, 93.395.
  • This funding opportunity was created on 2019-01-24.
  • Applicants must submit their applications by 2020-08-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA CA 19 032

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs): NIH RFA-CA-19-032 (HIV-Associated Cancers, R01)

1) What is this funding opportunity?

This is a National Institutes of Health (NIH) funding opportunity announcement (FOA) from the National Cancer Institute (NCI), identified as RFA-CA-19-032. It supports R01 research grant applications focused on cancers that occur in people living with HIV or with a diagnosis of AIDS.

2) What is the main goal of the FOA?

The central aim is to improve understanding of HIV-associated cancers, including cancer risk, how these malignancies develop and progress, how they can be diagnosed more effectively, and how they can be treated in the context of underlying HIV infection.

3) What makes this FOA different from a general HIV-and-cancer research announcement?

This FOA is intentionally targeted. It is structured around a small set of specific research challenges called "Provocative Questions" (PQs). The intent is to push research toward understudied problems and apparent paradoxes in HIV-associated cancer research rather than cover the entire range of NCI priorities in this space.

4) What are "Provocative Questions" (PQs) in this FOA?

PQs are a defined set of focused research questions designated by the FOA. They are designed to direct applicants toward specific, high-impact gaps in knowledge related to cancers in people living with HIV or with AIDS.

5) How many Provocative Questions can a single application address?

Each application must choose one and only one of the six designated Provocative Questions and build the project around that single selected question.

6) Can an application include multiple unrelated aims if they are all about HIV-associated cancer?

The project is not meant to be a broad program covering multiple unrelated aims. The FOA emphasizes a coherent, well-justified project that directly addresses the single selected PQ.

7) Does the FOA require a hypothesis-driven project?

The FOA describes the desired project as coherent and hypothesis-driven, or otherwise rigorously justified, as long as it directly addresses the selected PQ.

8) Are transdisciplinary or cross-cutting approaches allowed?

Yes. The FOA encourages cross-cutting, transdisciplinary approaches when they strengthen the science behind the chosen PQ, as long as the work remains clearly focused on the single PQ target.

9) What kinds of disciplines or methods can be combined in an application?

The FOA indicates that applicants may combine methods and perspectives from multiple fields, such as oncology, virology, immunology, epidemiology, genomics, implementation science, behavioral science, pathology, bioinformatics, or health services research, provided the work stays centered on the selected PQ.

10) What type of grant mechanism is used?

The grant mechanism is an NIH R01.

11) Are clinical trials allowed under this FOA?

Clinical trials are listed as optional. Applicants may propose non-clinical-trial research or include a clinical trial component if it is appropriate to answering the selected PQ and meets NIH requirements.

12) What is the activity category for this opportunity?

The activity category is health and education.

13) What CFDA numbers are associated with this program?

The program is associated with CFDA numbers 93.393 and 93.395.

14) Is an award ceiling or maximum budget stated in the provided information?

No. The provided source information does not include an award ceiling.

15) Does the provided information say how many awards NIH/NCI expects to make?

No. The provided source information does not include an expected number of awards.

16) Who is eligible to apply (in general terms)?

Eligibility is broad. It includes many types of U.S.-based organizations and also certain non-U.S. entities, including foreign (non-U.S.) organizations.

17) What types of U.S. government entities are eligible?

Eligible applicants include state governments; county governments; city or township governments; special district governments; and U.S. territories or possessions.

18) Are educational institutions eligible?

Yes. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, independent school districts, and a range of designated serving institutions (for example, HBCUs and Hispanic-serving Institutions).

19) Are tribal governments and tribal organizations eligible?

Yes. Eligibility includes federally recognized Native American tribal governments and tribal organizations that are not federally recognized.

20) Are nonprofits eligible?

Yes. Nonprofit organizations with or without 501(c)(3) status (when not an institution of higher education) are eligible.

21) Are for-profit entities eligible?

Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.

22) Are housing authorities eligible?

Yes. Public housing authorities and Indian housing authorities are listed as eligible.

23) Are faith-based and community-based organizations eligible?

Yes. The FOA explicitly calls out faith-based and community-based organizations as eligible applicants.

24) Are federal agencies eligible to apply?

Yes. Eligible federal agencies are specifically listed among eligible applicant categories.

25) Are regional organizations eligible?

Yes. Regional organizations are included in the FOA's stated eligible applicant categories.

26) Are foreign (non-U.S.) organizations eligible?

Yes. Foreign (non-U.S.) organizations are explicitly included as eligible applicants.

27) When was this opportunity created?

The opportunity was created on January 24, 2019.

28) What is the closing date shown in the provided information?

The original closing date shown in the source data is August 3, 2020.

29) What topic area should an application focus on?

The application should focus on cancers occurring in people living with HIV or with a diagnosis of AIDS, and it must be designed specifically to address one of the FOA's six Provocative Questions.

30) What is the key compliance point applicants should keep in mind from the FOA description provided?

The proposal must be tightly aligned to the PQ format: select a single PQ (one of six) and design the project so that the aims, rationale, and methods directly address that question without drifting into a broad or multi-topic program.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Higher Education Multicultural Scholars Program

Previous opportunity: Versatile modular gasification technology for competitive markets

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA CA 19 032

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA CA 19 032) also looked into and applied for these:

Funding Opportunity
HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required) Apply for RFA AI 19 003

Funding Number: RFA AI 19 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 19 169

Funding Number: PAR 19 169
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 19 168

Funding Number: PAR 19 168
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Administrative Supplements to NCI Grant and Cooperative Agreement Awards to Support Collaborations with the PDX Development and Trial Centers Research Network (PDXNet) (Admin Supp Clinical Trial Not Allowed) Apply for PA 19 174

Funding Number: PA 19 174
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed) Apply for RFA CA 19 010

Funding Number: RFA CA 19 010
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 19 011

Funding Number: RFA CA 19 011
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 19 184

Funding Number: PAR 19 184
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 19 183

Funding Number: PAR 19 183
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Apply for PAR 19 194

Funding Number: PAR 19 194
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) Apply for PA 19 196

Funding Number: PA 19 196
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Apply for PAR 19 193

Funding Number: PAR 19 193
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Apply for PA 19 201

Funding Number: PA 19 201
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Apply for PA 19 200

Funding Number: PA 19 200
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) Apply for PAR 19 207

Funding Number: PAR 19 207
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) Apply for PAR 19 212

Funding Number: PAR 19 212
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) Apply for PAR 19 213

Funding Number: PAR 19 213
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 19 223

Funding Number: PAR 19 223
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
ITCR: innovative algorithms (R21 Clinical Trial Optional) Apply for RFA CA 19 038

Funding Number: RFA CA 19 038
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 19 039

Funding Number: RFA CA 19 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Apply for RFA CA 19 041

Funding Number: RFA CA 19 041
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 19 032", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: